|
Market Cap (4-Jul) $3,153,122 (199th) |
Close (30-Jun) $0.091 |
Volume (30-Jun) 50,159,971 |
Shortsold (19-Jun) 392,315,164 (5.25%) (41st) |
|
52w High $2.75 |
52w Low $0.340 |
P/E - |
EPS -0.6 |
IMU released this announcement to the ASX on 16 November 2021, 8:15. The announcement is marked as price sensitive, and is 2 page(s) in length and 124.99kb in size.
You can view all announcements from IMU and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMU was 2.160% short sold according to ASIC data. It was ranked the 90th most shorted stock on the ASX. It is now ranked as the 41st most shorted stock on the ASX with 5.254% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMU | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 16:33 |
| HER-Vaxx induced antibodies correlated with tumour reduction | 30 June 2023, 8:40 |
| Imugene PD1-Vaxx patent extended to 2040 | 29 June 2023, 8:39 |
| Clinical Trial Supply Agreement with Merck KGaA and Pfizer | 16 November 2021, 8:15 |
| Application for quotation of securities - IMU | 12 November 2021, 17:05 |
| Eureka Strategic Collaboration (supplementary announcement) | 9 November 2021, 19:26 |
| Application for quotation of securities - IMU | 5 November 2021, 17:13 |
You must be logged in to post a reply.
Imugene 